Jasper Therapeutics Stock Current Valuation
| JSPR Stock | USD 2.73 0.17 5.86% |
Valuation analysis of Jasper Therapeutics helps investors to measure Jasper Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Jasper Therapeutics' price fluctuation is slightly risky at this time. Calculation of the real value of Jasper Therapeutics is based on 3 months time horizon. Increasing Jasper Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Jasper stock is determined by what a typical buyer is willing to pay for full or partial control of Jasper Therapeutics. Since Jasper Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jasper Stock. However, Jasper Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.73 | Real 14.59 | Hype 2.89 | Naive 3.21 |
The intrinsic value of Jasper Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Jasper Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Jasper Therapeutics helps investors to forecast how Jasper stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jasper Therapeutics more accurately as focusing exclusively on Jasper Therapeutics' fundamentals will not take into account other important factors: Jasper Therapeutics Company Current Valuation Analysis
Jasper Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Jasper Therapeutics Current Valuation | (1.44 M) |
Most of Jasper Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jasper Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Jasper Therapeutics has a Current Valuation of (1.44 Million). This is 100.01% lower than that of the Biotechnology sector and 100.03% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.01% higher than that of the company.
Jasper Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jasper Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jasper Therapeutics could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics of similar companies.Jasper Therapeutics is currently under evaluation in current valuation category among its peers.
Jasper Fundamentals
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.56 | ||||
| Current Valuation | (1.44 M) | ||||
| Shares Outstanding | 15.02 M | ||||
| Shares Owned By Insiders | 1.27 % | ||||
| Shares Owned By Institutions | 89.64 % | ||||
| Number Of Shares Shorted | 1.36 M | ||||
| Price To Book | 1.06 X | ||||
| EBITDA | (71.39 M) | ||||
| Net Income | (71.27 M) | ||||
| Cash And Equivalents | 60.81 M | ||||
| Cash Per Share | 1.60 X | ||||
| Total Debt | 1.81 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.56 X | ||||
| Book Value Per Share | 2.81 X | ||||
| Cash Flow From Operations | (62.6 M) | ||||
| Short Ratio | 0.93 X | ||||
| Earnings Per Share | (5.27) X | ||||
| Target Price | 20.13 | ||||
| Number Of Employees | 64 | ||||
| Beta | 2.71 | ||||
| Market Capitalization | 44.77 M | ||||
| Total Asset | 79.9 M | ||||
| Retained Earnings | (240.87 M) | ||||
| Working Capital | 60.57 M | ||||
| Net Asset | 79.9 M |
About Jasper Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jasper Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.